Scottsdale, Ariz.-based HonorHealth researchers developed a novel drug combination therapy for pancreatic cancer patients that has become part of the new National Comprehensive Cancer Network guidelines for the disease, the system shared with Becker’s.
Read the full post on Becker's Hospital Review - Healthcare News
